Sarepta Therapeutics (SRPT) Enterprise Value (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Enterprise Value of -$405.6 million for Q1 2026, up 22.42% year-over-year from -$331.3 million in Q1 2025, and up 56.84% quarter-over-quarter from -$939.6 million in Q4 2025.
Sarepta Therapeutics (SRPT) Enterprise Value (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$405.6 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 22.42% year-over-year to -$405.6 million; the TTM figure through Mar 2026 stood at -$405.6 million (up 22.42% YoY), while the FY2025 annual figure was -$939.6 million, up 14.26% from the prior year.
- Enterprise Value for Q1 2026 stood at -$405.6 million, up from -$939.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$242.5 million in Q3 2024, with the low at -$2.1 billion in Q3 2022.
- The 5-year median for Enterprise Value is -$1.5 billion (2024), against an average of -$1.3 billion.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 86.01% in 2024, then sank 164.96% in 2025.
- Sarepta Therapeutics' Enterprise Value stood at -$2.0 billion in 2022, then climbed by 15.74% to -$1.7 billion in 2023, then surged by 34.62% to -$1.1 billion in 2024, then advanced by 14.26% to -$939.6 million in 2025, then surged by 56.84% to -$405.6 million in 2026.
- Business Quant data shows SRPT's Enterprise Value at -$405.6 million in Q1 2026, -$939.6 million in Q4 2025, and -$642.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | -794.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -794.38 Mn |
| Mar 31, 2026 | -405.56 Mn |
| Dec 31, 2025 | -939.65 Mn |
| Sep 30, 2025 | -642.47 Mn |
| Jun 30, 2025 | -442.81 Mn |
| Mar 31, 2025 | -522.76 Mn |
| Dec 31, 2024 | -1.10 Bn |
| Sep 30, 2024 | -242.48 Mn |
| Jun 30, 2024 | -1.46 Bn |
| Mar 31, 2024 | -1.39 Bn |
| Dec 31, 2023 | -1.68 Bn |
| Sep 30, 2023 | -1.73 Bn |
| Jun 30, 2023 | -1.86 Bn |
| Mar 31, 2023 | -1.88 Bn |
| Dec 31, 2022 | -1.99 Bn |
| Sep 30, 2022 | -2.07 Bn |
| Jun 30, 2022 | -1.93 Bn |
| Mar 31, 2022 | -2.01 Bn |
| Dec 31, 2021 | -2.12 Bn |
| Sep 30, 2021 | -1.60 Bn |